IQVIA Holdings Inc. IQV

270.37 (4.65) (1.69%) as of 25 Sep
Market cap
$45.3B
P/E
33.3×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years

IQVIA Holdings Inc. (IQV) Operating margin

IQVIA Holdings Inc.'s operating margin over the twelve months to 30 June 2026 was 13.0%, down 0.4 percentage points from fiscal 2025 (13.4%). Over the past ten years it has ranged from 6.44% (fiscal 2020) to 14.3% (fiscal 2024); the current reading is higher than 91% of that period. That is above the Diagnostics & Research industry median of −8.57% and above the Healthcare sector median of 0.00%.

Operating margin, annual

Annual

Period Operating margin Change (points)
FY2025 13.4% (0.91)
FY2024 14.3% 1.10
FY2023 13.2% 0.71
FY2022 12.5% 2.44
FY2021 10.0% 3.60
FY2020 6.44% (0.57)
FY2019 7.01% (0.11)
FY2018 7.12% 0.27
FY2017 6.85% (1.60)
FY2016 8.45% (2.81)

Quarterly

Period Operating margin Change (points)
Jun 2026 11.6% (0.80)
Mar 2026 12.4% (1.99)
Dec 2025 14.4% 0.88
Sep 2025 13.5% 0.89
42 more quarters

Against its own ten years

Low 6.44% High 14.3%
Ten-year median 10.0%
Current reading's percentile 91

Operating margin against peers

Company Operating margin
IDXX IDEXX Laboratories, Inc. compare 32.0%
MTD Mettler-Toledo International, Inc. compare 28.4%
A Agilent Technologies, Inc. compare 22.2%
ILMN Illumina, Inc. compare 19.7%
DGX Quest Diagnostics Incorporated compare 14.1%
IQV IQVIA Holdings Inc. 13.0%
WAT Waters Corporation compare 7.10%
NTRA Natera, Inc. compare −10.7%
GH Guardant Health, Inc. compare −39.8%
Diagnostics & Research industry median −8.57%
Healthcare sector median 0.00%
Market median 0.00%

What Operating margin is

EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.

EBIT ÷ Revenue

The full definition of Operating margin →

More on IQV